Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients

被引：0
|
作者：
Malani, Ashok K. [1 ]
Abou-Jawde, Rony M.
Singh, Jaswinder
Taylor, Sarah A.
机构：
[1] Heartland Reg Med Ctr, Dept Hematol Oncol, St Joseph, MO USA
[2] Univ Kansas, Med Ctr, Dept Hematol & Oncol, Kansas City, KS 66103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 09期
关键词：
D O I：
10.1200/JCO.2006.09.0043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1143 / 1144
页数：3
相关论文
共 50 条
  • [31] Treatment of elderly patients with stage IV non-small-cell lung cancer
    Weiss, Jared
    Stinchcombe, Thomas E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (01) : 111 - 120
  • [32] Gefitinib Monotherapy in Advanced non-small-cell Lung Cancer: A Retrospective Analysis
    Shrestha, S.
    Joshi, P.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2012, 52 (02) : 66 - 71
  • [33] Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Davidoff, Amy J.
    Tang, Mei
    Seal, Brian
    Edelman, Martin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2191 - 2197
  • [34] CONTINUATION MAINTENANCE FOR ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Okamoto, Isamu
    ANNALS OF ONCOLOGY, 2014, 25
  • [35] Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer
    C Gridelli
    P Maione
    V Castaldo
    A Rossi
    British Journal of Cancer, 2003, 89 : 1827 - 1829
  • [36] Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer
    Gridelli, C
    Maione, P
    Castaldo, V
    Rossi, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1827 - 1829
  • [37] Treatment principles in advanced non-small-cell lung cancer
    Scott, CL
    Zalcberg, JR
    Irving, LB
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1996, 66 (10): : 688 - 693
  • [38] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [39] Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer
    Syrios, John
    Nintos, Georgios
    Georgoulias, Vassilis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (08) : 875 - 884
  • [40] Afatinib for the treatment of advanced non-small-cell lung cancer
    Genova, Carlo
    Rijavec, Erika
    Barletta, Giulia
    Burrafato, Giovanni
    Biello, Federica
    Dal Bello, Maria Giovanna
    Coco, Simona
    Truini, Anna
    Alama, Angela
    Boccardo, Francesco
    Grossi, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (06) : 889 - 903
12345